Stockreport

Kymera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13

Kymera Therapeutics, Inc.  (KYMR) 
PDF WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral [Read more]